Single Mission: To fund innovative cancer research
For millions of people worldwide Terry Fox is the face of hope for cancer research. In 1980 his Marathon of Hope inspired a country and launched the annual The Terry Fox Run in his honour. Now in its fourth decade, these events continue to motivate people here in Canada and around the world, raising much needed funds for cancer research.
The Terry Fox Foundation continues to be a leading national investor in cancer research, directing $21.8 million to its cancer research programs in 2017/18.
Our $0.21 fundraising cost ratio is one of the best in the Canadian not-for-profit sector
Our research focus is multi-site, including lung, brain, pediatric, and more
We invest in research with the potential for best and fastest outcomes
Terry Fox Research Institute
Launched in October 2007, The Terry Fox Research Institute is the brainchild of The Terry Fox Foundation. The Institute seeks to improve significantly the outcomes of cancer research for the patient through a highly collaborative, team-oriented, milestone-based approach to research that will enable discoveries to translate quickly into practical solutions for cancer patients worldwide. TFRI collaborates with over 70 cancer hospitals and research organizations across Canada. We also function as the research arm of The Terry Fox Foundation. Our headquarters are in Vancouver. We have regional nodes in Atlantic Canada, the Prairies, British Columbia, Alberta, Ontario and Quebec.
TFRI allocates funds raised by donors of the Terry Fox Foundation to the most promising projects based on:
The project’s excellence and potential for impact as judged by international scientific peers
Projects are milestone driven and have significant deliverables
Projects are actively managed, with those deemed unproductive terminated
Cancer Research Investment
Our research funds many different types of cancers. Current multi-year studies include lung, breast, ovarian, colorectal, prostate, brain, oral and blood cancers as well as promising therapies such as oncolytic viruses and immunotherapies.
1,314 – the number of cancer research projects funded to date in Canada by The Foundation
In 2017-18, TFF has invested an estimated $21.8 million in cancer research in three key areas:
Discovery research – fundamental science, cure-oriented biomedical: $14.3 million
Translational research – moving discoveries from the laboratory in the clinic more quickly to impact patients; “lab bench to bedside” approach: $5.7 million Training future leaders in cancer research – $1.8 million